Skip to main content
Clinical Trials/NCT06204575
NCT06204575CompletedNot Applicable

Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkinsonism

Rambam Health Care Campus1 site in 1 country8 target enrollmentStarted: November 1, 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
8
Locations
1
Primary Endpoint
Clinical Rating Scale for Tremor

Study Overview

Brief Summary

The goal of this retrospective observational study is to describe the efficacy of focused ultrasound ventral-intermediate nucleus thalamotomy in patients with atypical parkinsonism.

  • Is this treatment efficacious in patients with multiple system atrophy?
  • Is this treatment efficacious in patients with diffuse Lewy Body Dementia? Data will be collected from patients charts.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients that did not underwent FUS ventral-intermediate nucleus thalamotomy
  • Patients that underwent FUS ventral-intermediate nucleus thalamotomy and do not suffer from MSA or DLBD

Outcomes

Primary Outcomes

Clinical Rating Scale for Tremor

Time Frame: baseline, pre-procedure, 1 month, 6 months and 1 year following procedure

tremor assessment by Clinical Rating Scale for Tremor. Scores ranging from 0 to 156, with higher scores indicating more severe tremor.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ilana Schlesinger

Director Movement Disorders Institute, clinical senior lecturer, Chair of Neurology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology Haifa, Israel

Rambam Health Care Campus

Study Sites (1)

Loading locations...

Similar Trials